Ilaria Del Giudice

16PUBLICATIONS
49CO-AUTHORS
Haematological tumoursHaematologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Feb 21, 2026
Prognostic impact of treatment-related and geriatric factors in older patients with classic Hodgkin lymphoma: A real-life cohort study.

Silvio Ligia, Giovanni Manfredi Assanto, Tania Soriano

|Jul 14, 2025
Predicting thrombotic risk in patients with classical Hodgkin lymphoma: Thro-HL multicenter study.

Giovanni Manfredi Assanto, Eleonora Alma, Alessandro Cellini

|Jun 19, 2024
Monitoring Response and Resistance to Treatment in Chronic Lymphocytic Leukemia.

Ilaria Del Giudice, Irene Della Starza, Filomena De Falco

|Aug 15, 2023
XPO1 mutations identify early-stage CLL characterized by shorter time to first treatment and enhanced BCR signalling.

Riccardo Moia, Lodovico Terzi di Bergamo, Donatella Talotta

|Dec 30, 2020
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases.

Fortunato Morabito, Giovanni Tripepi, Giovanni Del Poeta

Pageof 3